丹皮酚通过NF-κB通路改善腹主动脉瘤进展
本研究在C57BL/6J小鼠中通过主动脉内灌注猪胰弹性蛋白酶建立实验性腹主动脉瘤模型,随后灌胃给予丹皮酚(20 mg/kg/天)14天。结果显示丹皮酚治疗限制了动脉瘤直径增大,减轻弹性纤维和血管平滑肌细胞耗竭,并减少CD68+巨噬细胞和CD8+淋巴细胞浸润及壁内新生血管形成。Western blot显示丹皮酚抑制基质金属蛋白酶表达和NF-κB通路激活,提示其可能通过抑制NF-κB通路预防实验性腹主动脉瘤进展。
要点
- 丹皮酚(20 mg/kg/天,14天)可限制弹性蛋白酶诱导的小鼠腹主动脉瘤直径增大。
- 丹皮酚减轻弹性纤维和血管平滑肌细胞耗竭,减少巨噬细胞和CD8+淋巴细胞浸润。
- 丹皮酚抑制基质金属蛋白酶表达和NF-κB通路激活,提示其可能为腹主动脉瘤潜在药物。
核心结论
- 丹皮酚可能通过抑制NF-κB通路预防实验性腹主动脉瘤进展,提示其是腹主动脉瘤的潜在药物。
研究设计与样本
- 在C57BL/6J小鼠中通过主动脉内灌注猪胰弹性蛋白酶建立实验性腹主动脉瘤模型,随后灌胃给予丹皮酚(20 mg/kg/天)14天。
- 通过超声成像、组织病理学和Western blot分析评估丹皮酚对实验性腹主动脉瘤的影响。
主要发现
- 丹皮酚治疗限制了动脉瘤直径的增大。
- 丹皮酚减轻了弹性纤维和血管平滑肌细胞的耗竭。
- 丹皮酚给药后CD68+巨噬细胞和CD8+淋巴细胞浸润明显减弱,同时壁内新生血管形成减少。
- Western blot结果显示丹皮酚抑制基质金属蛋白酶表达和NF-κB通路激活。
临床怎么用
- 丹皮酚可能作为抑制NF-κB通路的潜在药物用于延缓腹主动脉瘤进展,但需进一步临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Abdominal aortic aneurysm (AAA) is a chronic inflammatory disease characterized by localized progressive dilatation. Currently, paeonol has been shown to possess anti-inflammatory and protective cardiovascular properties. Our study aimed to investigate the potential influences of paeonol on AAA progression. METHODS: Experimental AAAs were created in C57BL/6J mice by intra-aortic infusion of porcine pancreatic elastase, and then intragastrically administered paeonol (20 mg/kg/day) for 14 days. The effects of paeonol on experimental AAA were measured by ultrasound imaging, histopathology, and western blot analyses. RESULTS: Paeonol treatment limited the enlargement of the aneurysmal diameter and alleviated the depletion of elastic fibers and vascular smooth muscle cells (VSMCs). Furthermore, the infiltration of CD68+ macrophages and CD8+ lymphocytes was obviously attenuated after paeonol administration, along with mural neoangiogenesis. Western blot results showed that paeonol inhibited the expression of matrix metalloproteinase (MMP) and the NF-κB pathway activation. CONCLUSIONS: Paeonol might prevent experimental AAA progression by inhibiting the NF-κB pathway, which suggests that it is a potential drug for AAA.
引用
- Chen S, Luo K, Bian S, et al. Paeonol Ameliorates Abdominal Aortic Aneurysm Progression by the NF-κB Pathway. Ann Vasc Surg. 2021. PMID: 34411666. doi:10.1016/j.avsg.2021.06.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。